CX-3543 Promotes Cell Apoptosis through Downregulation of CCAT1 in Colon Cancer Cells.
Yu-Xia YaoBao-Hong XuYan ZhangPublished in: BioMed research international (2018)
Our study demonstrated that CX3543 could inhibit the progression of colon cancer by downregulating CCAT1 expression and might be a potential drug for the treatment of colon cancer.